
Researchers from the Mount Sinai COVID Informatics Center report improved survival rates in COVID patients treated with anticoagulants. Results of the study demonstrated that hospitalized COVID-19 patients treated with anticoagulants had improved outcomes both in and out of the intensive care unit setting, without a significant difference in bleeding.

















































































